The role of IGF‐I and its binding proteins in the development of type 2 diabetes and cardiovascular disease
- 20 February 2007
- journal article
- review article
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 10 (3) , 198-211
- https://doi.org/10.1111/j.1463-1326.2007.00709.x
Abstract
Patients with insulin resistance and type 2 diabetes have an excessive risk of cardiovascular disease (CVD); this increased risk is not fully explained by traditional risk factors such as hypertension and dyslipidaemias. There is now compelling evidence to suggest that abnormalities of insulin-like growth factor-I (IGF-I) and one of its binding proteins, insulin-like growth factor-binding protein-1 (IGFBP-1), occur in insulin-resistant states and may be significant factors in the pathophysiology of CVD. We reviewed articles and relevant bibliographies following a systematic search of MEDLINE for English language articles between 1966 and the present, using an initial search strategy combining the MeSH terms: IGF, diabetes and CVD. Our aim was first to review the role of IGF-I in vascular homeostasis and to explore the mechanisms by which it may exert its effects. We also present an overview of the physiology of the IGF-binding proteins, and finally, we sought to summarize the evidence to date describing the changes in the insulin/IGF-I/IGFBP-1 axis that occur in type 2 diabetes and CVD; in particular, we have focused on the potential vasculoprotective effects of both IGF-I and IGFBP-1. We conclude that this system represents an interesting and novel therapeutic target in the prevention of CVD in type 2 diabetes.Keywords
This publication has 145 references indexed in Scilit:
- Regulation of Insulin-Like Growth Factor-I (IGF-I) Delivery by IGF Binding Proteins and ReceptorsAnnals of Biomedical Engineering, 2006
- Endogenous Hormones and Carotid Atherosclerosis in Elderly MenAmerican Journal of Epidemiology, 2003
- Direct Functional Interactions between Insulin-like Growth Factor-binding Protein-3 and Retinoid X Receptor-α Regulate Transcriptional Signaling and ApoptosisJournal of Biological Chemistry, 2000
- Determinants of atherosclerosis in the youngThe American Journal of Cardiology, 1998
- Signaling via the insulin-like growth factor-I receptor: Does it differ from insulin receptor signaling?Cytokine & Growth Factor Reviews, 1996
- Insulin-like growth factor-1 and angiographically documented coronary artery diseaseThe American Journal of Cardiology, 1996
- Multiple proteins bind the insulin response element in the human IGFBP-1 promoterProgress in Growth Factor Research, 1995
- Randomized double-blind Scandinavian trial of angiopeptin versus placebo for the prevention of clinical events and restenosis after coronary balloon angioplastyAmerican Heart Journal, 1995
- Comparison of the metabolic effects of recombinant human insulin-like growth factor-I and insulin. Dose-response relationships in healthy young and middle-aged adults.Journal of Clinical Investigation, 1994
- Prognosis of patients with diabetes mellitus after acute myocardial infarctionThe American Journal of Cardiology, 1984